vVardis – the recently launched personal oral care brand by Dres Abivardi – has acquired credentis. credentis and vVardis previous partnership has already yielded the unique vVardis oral care product line, and now credentis will become the research and development department within vVardis.

Following the acquisition of credentis by vVardis, both the professional dental CURODONT™ line and the oral care vVardis products – both with the proprietary CUROLOX® & WX Technology – will form one oral care powerhouse. Within the newly formed partnership, credentis leadership team will continue to run credentis in order to accelerate the research and development of revolutionary oral care and dental products. For the credentis investors the acquisition by vVardis represents a successful exit, concluding a nearly decade long collaboration.

“I am overjoyed that we managed to establish credentis as an innovative dental and oral care company, that has become a successful investment case. Furthermore, with this acquisition the value generated will remain and support growth in Switzerland.”, says Dr Erich Platzer, former President of the Board of Directors of credentis, and lead investor for the business angel group, StartAngelsNetwork.

“This is a dream coming true – after 10 years of scientific research and development of our unique CUROLOX® TECHNOLOGY and the CURODONT™ products, we will take the next step – establishing the credentis and vVardis products in the dental and OTC markets.”, says Dr Dominik Lysek, CEO of credentis.

“For us, the combination of credentis’ scientific expertise and innovation, and our unique vVardis brand based on our expertise in Dentistry and Oral Care makes the perfect team to revolutionize the oral care and dental market with the best products possible.”, say the Dres Haleh and Golnar Abivardi, CEOs of vVardis.

About credentis ag

credentis ag is headquartered in Switzerland. credentis has won multiple awards as well as multiple public grants include Swiss National Science Foundation (SNF), Aargauer Forschungsfonds, CTI, and the Medical Technologies IKC. Dr. Dominik Lysek, CEO and Michael Hug, COO have a strong track record in science, development and medical technology, with focus in the dental and oral care industry. credentis would like to thank their board members – Dr. Werner Berner, Dr. Michael Peetz, Gerard Moufflet and Dr. Erich Platzer (chairman) – for the successful team effort throughout the past decade.


The patented CUROLOX® is based on peptides self-assembling into a 3-dimensional matrix, triggering biomimetic mineralisation and repair from calcium, phosphate and fluoride. CUROLOX® is the basis for all innovative credentis products. With its CURODONT™ product line, credentis supports the trend towards prevention and early treatment. CURODONT™ REPAIR & CURODONT™ REPAIR FLUORIDE PLUS provide dentists with a non-invasive option for natural in-depth mineralisation or Guided Enamel Remineralization (GER) which enables the regeneration of caries lesions and similar defects. CURODONT™ PROTECT uses CUROLOX® to protect the tooth surface from acid attack. CURODONT™ D’SENZ & CURODONT™ FOR SENSITIVE TEETH are optimised for the treatment of dentine hypersensitivity, for in-office and home use.

About vVardis

vVaris was founded by the two highly successful entrepreneurs Dres Haleh and Golnar Abivardi, who have built up the first Swiss Dental Service Organization Swiss Smile which was acquired by Colosseum Dental three years ago. At the heart of vVardis oral care products is proprietary CUROLOX® as well as the WX formula, which enable a true oral care and dental powerhouse. Sales of vVardis products have already started in the USA and Switzerland. The unique hydroxyapatite-based WX formula with CUROLOX® ensures a long-lasting and at the same time tooth-caring whitening effect. Give it a try: The products are available at www.vvardis.com .